EXAR CORP - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - August 11, 2011



Attached files
FileFilename
EXCEL - IDEA: XBRL DOCUMENT - EXAR CORPFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - EXAR CORPR9.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR7.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR4.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR3.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR1.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR8.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR2.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR6.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR10.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR17.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR14.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR18.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR22.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR21.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR12.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR16.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR19.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR15.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR11.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR13.htm
XML - IDEA: XBRL DOCUMENT - EXAR CORPR20.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - EXAR CORPdex321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) OR 15D-14(A) - EXAR CORPdex311.htm
EX-10.1 - FISCAL YEAR 2012 EXECUTIVE INCENTIVE PROGRAM - EXAR CORPdex101.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - EXAR CORPdex322.htm
10-Q - FORM 10-Q - EXAR CORPd10q.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) OR 15D-14(A) - EXAR CORPdex312.htm
People who read this document also read:
Document
BREEZE-EASTERN CORP - 8-K, Results of Operations and Financial Condition Financial Statements and Exhibits
v2.3.0.11
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands
3 Months Ended
Jul. 03, 2011
Jun. 27, 2010
Cash flows from operating activities:    
Net loss $ (1,426) $ (7,414)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation and amortization 3,520 5,573
Stock-based compensation expense 884 3,322
Tax effect on other comprehensive income (183) 0
Changes in operating assets and liabilities:    
Accounts receivable and accounts receivable, related party (4,257) (412)
Inventories 1,797 (3,814)
Other current and non-current assets (31) 163
Accounts payable 722 1,351
Accrued compensation and related benefits (520) (247)
Deferred income and allowance on sales to distributors and related party distributor 2,142 871
Other accrued expenses (646) (362)
Net cash provided by (used in) operating activities 2,002 (969)
Cash flows from investing activities:    
Purchases of property, plant and equipment and intellectual property, net (521) (1,676)
Purchases of short-term marketable securities (21,946) (41,226)
Proceeds from maturities of short-term marketable securities 14,676 15,864
Proceeds from sales of short-term marketable securities 14,406 12,201
Other disposal (investment) activities 65 (103)
Net cash provided by (used in) investing activities 6,680 (14,940)
Cash flows from financing activities:    
Proceeds from issuance of common stock 336 233
Payments of lease financing obligations (705) (747)
Net cash used in financing activities (369) (514)
Net increase (decrease) in cash and cash equivalents 8,313 (16,423)
Cash and cash equivalents at the beginning of period 15,039 25,486
Cash and cash equivalents at the end of period 23,352 9,063
Supplemental disclosure of non-cash investing and financial activities:    
Return of Hillview Facility to Lessor 12,167 0
Property, plant and equipment acquired under capital lease $ 0 $ 1,208

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by EXAR CORP and has no official or unofficial affiliation with EXAR CORP


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.